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INTRODUCTION 
 
 Dysfunctional uterine bleeding is one of the most frequently 
encountered conditions in gynaecologic practice and forms about 10% 
of all gynaecological admissions. 
 
 In Government Raja Sir Ramasamy Mudaliar Lying – In Hospital 
in the year 2005-2006, 520 cases of the 2200 admissions in the 
department of gynaecology were for Dysfunctional uterine bleeding 
giving an incidence of 23.6% of these  
 
 5% - < 20 years (Pubertal age group) 
 57% - 20 - 40 years (Reproductive age group) 
 38% - > 40 years (Perimenopausal & Postmenopausal bleeding) 
 
 The main concern in permenopausal bleeding and 
postmenopausal bleeding is, that the bleeding could be the only 
external manifestation of a hidden serious pathology such as 
endometrial carcinoma. Also, endometrial hyperplasia which is a 
forerunner of endometrial carcinoma is a common finding in women 
with perimenopausal bleeding. 
 
 The incidence of endometrial carcinoma is rising both relative to 
cancer cervix and in absolute terms and the disease which was 
formerly confined to the postmenopausal women is now occurring 
with increased frequency in middle age and perimenopausal women 
(Arthur et al)1. Also with the advent of hormone replacement therapy 
postmenopausal women require constant surveillance of their 
endometrium.  
 
 Curettage has long been considered to be the gold standard for 
the diagnosis of perimenopausal and postmenopausal uterine 
bleeding. But dilatation and curettage has many shortcomings.  
 
 Dilatation and curettage has a failure rate of 12-29% (Arthur et 
al). Undirected sampling whether through curettage or suction 
aspiration is fraught with error in cases in which the abnormality is 
not global but focal.  
 Hysteroscopy is the endoscopic technique of visualizing the 
interior of the uterus directly. Improvements in instrumentation, 
optics and addition of operative capabilities, have led to a resurgence 
of interest in hysteroscopy worldwide.  
 
 Histerscopic guided biopsy gives more reliable and accurate 
diagnosis than blind dilatation and curettage procedure.  
 
 With the advent of transvaginal sonogram gynaecologists now 
have a simple outpatient method of studying the endometrium for 
detecting malignant lesions or their precursors at an earlier stage. 
 
 The thickness and internal echo texture of the endometrium in 
the various phases of the menstrual cycle as seen in Transvaginal 
Sonogram correlates well with endometrial histology. 
 
 The echogenicity of the endometrium has certain characteristics 
during the various phases of the menstrual cycle, thus enabling the 
histology to be evaluated with precision by examining with TVS. 
 
 During the early proliferative phase the endometrial thickness is 
2-4 mm. Endometrium functionalis is hypoechoic or isoechoic and 
endometrium basalis echogenic. 
 
 During the periovulatory phase the endometrium has trilaminar 
appearance or Triple sign-lumen is echogenci surrounding which 
there is hypoechoic endometrium functionalis and the echogenic 
endometrium basalis. The thickness ranges from 6-12 mm. 
 
 During the secretory phase, the whole endometrium from 
basalis to lumen is very echogenic. The greatest thickness is achieved 
during secretory phase measuring upto 14 mm in width. 
 
 In postmenopausal patients less than 4-5 mm or a thin pencil 
line echo is usually associated with Tissue insufficient for Diagnosis. 
Normal thickness in postmenopausal patients is 4-8 mm. 
 
 Endometrial carcinoma is diagnosed at an earlier stage by loss 
of the subendometrial halo and later myometrial invasion is accurately 
documented. 
 
 Other pathologic conditions of the endometrium and 
myometrium such as myomatous polups, endometrial polyps and 
Adenomyosis are also well visualised. 
 
 Thus with transvaginal sonogram the endometrial pathology can 
be visualized whereas Dilatation and curettage is a blind procedure. 
Thus the transvaginal sonogram can be used as an initial diagnostic 
procedure and it supplements the shortcomings of Dilatation and 
curettage. 
 
 This study proposes to correlate the findings of the two 
diagnostic modalities used in the evaluation of women with peri and 
postmenopausal bleeding namely transvaginal sonogram and 
histopathological examination.  
 
  REVIEW OF LITERATURE 
 
History of Ultrasound 
 
The word SONAR stands for sound navigation and Ranging. 
Sonar utilises a frequency of 3.5 MHz to 10 MHz beyond the range of 
human audibility limit. ultrasound travels at a speed of 1560 
m/second in human 
tissue. 
 
"Sergal sokolovin" a Russian Scientist is called as the "Father of 
ultrasound". He emphasized the potential importance of Sonar in 
1929. 
 
Dr.Karl Dussik in Austria applied ultrasound in medical 
diagnosis. 
 
In 1951, wild and Reig reported a 90% accuracy in the diagnosis 
of cystic versus solid lesions of various organs using the scan 
technique. 
 
In 1955, Ian Donald and Tom Brown designed the contact 
scanner. 
 
In 1961, Biparietal diameter was first measured by Ian Donald. 
About this time, Campbell began working on the growth patterns of 
fetus as measured by serial Biparietal diameter. In 1973 - gray scale 
presentation was introduced. Piezo electric effect was first discovered 
by Pierre Curie in 1880. 
 
Transvaginal ultrasound was first introduced in 1984 by 
Schwimer S.R. and Lebovic J who used a 5 MHz, 13 mm transducer 
that was not specifically designed for vaginal work. 
PERIMENOPAUSAL AND POSTMENOPAUSAL BLEEDING 
 
In both western and Asian studies the mean age of menopause 
is fairly constant at 50-51 years (Frommer 1964, Boulet et al 1990). 
 
Perimenopause is that interval around menopause that is 
associated with menstrual and endocrinologic alterations 
chronologically it taken as the above 40 age group. 
 
2.1 THE MAIN CAUSES OF PERIMENOPAUSAL BLEEDING 
INCLUDE 
 
Endometrial Hyperplasia    - 15-25% 
Benign lesion of the uterus – myomas   - 10% 
Dysfunctional uterine bleeding   - 15-20% 
Malignancies of the Reproductive tract - 10-15% 
Cancer cervix     - 10-12% 
Cancer endometrium    - 2-4% 
Adenomyosis     - 20-25% 
Exogenous estrogen therapy    
Miscellaneous causes as: 
Endometrial polyps 
End9metritis    - 10% 
Cervical polyp and erosion 
 
Rarely pregnancy related causes 
 
The main causes of postmenopausal bleeding include 
 
Endometrial atrophy    - 60-80% 
Endometrial polyps   - 2-12% 
Endometrial Hyperplasia   - 5-10% 
Estrogen Replacement Therapy - 15-25% 
Endometrial Cancer – Sarcoma - 10%  
Cancer Cervix    - 10% 
Atrophic Vaginitis    - 5-10% 
 
Endometrial Hyperplasia 
 
In the perimenopausal period, the menstrual cycles tend to 
become anovulatory and acyclical, with unapposed estrogen secretion 
leading to 
hyperplasia of the proliferative endometrium (Treolar et al 1967). 
 
Classification Risk of Progression to cancer 
(Percentage) 
Simple (cystic without atypia) 1 
Complex (Adenomatous without 
atypia) 
3 
Atypia : 
Simple (cystic with atypia) 
8 
Complex (adenomatous with 
atypia) 
29 
 
Fibroids are an important cause of perimenopausal bleeding. If 
a woman in the premenopausal and postmenopausal age group 
complains of irregular or continuous vaginal bleeding, the possibility 
of coincident uterine cancer should be excluded. 
Adenomyosis the disease often coexists with uterine 
fibromyomas and endometrial carcinoma. 
 
Endometrial atrophy is the most common endometrial finding 
in women with postmenopausal bleeding (60-80%) Endometrial biopsy 
often yields insufficient tissue or only blood clots and usually there is 
no additional bleeding after biopsy. 
 
Endometrial polyps account for 2-12% of postmenopausal 
bleeding. The diagnosis of polyps are often rissed by dilatation and 
curettage or office endometrial' biopsy. Malignant transformation in an 
endometrial polyp is estimated to be as high as 0.5% (Arthur et at). 
Unrecognised and untreated polyps may be a source of continued or 
recurrent bleeding leading eventually to unnecessary hysterectomy. 
 
Endometrial cancer: Premenopausal women with endometrial 
carcinoma invariably have abnormal uterine bleeding which is often 
characterized as menometrorrhagia or metropathia haemarrhagica. 
 
Recently certain factors had led to an increasing awareness of 
and emphasis on diagnosis and treatment of endometrial cancer. 
These include prolonged life expectancy, earlier diagnosis and 
postmenopausal use of hormone replacement therapy, the availability 
of easily applied diagnostic tools and a clearer understanding of the 
premalignant lesions of the endometrium. The incidence of 
endometrial carcinoma in India is 1.6% (Ratnam et al. 
 
Hormone replacement therapy: In postmenopausal women on 
hormone replacement therapy, it has been suggested that endometrial 
sampling is indicated in any bleeding that occurs beyond the expected 
time of withdrawal following progestin therapy. In patients on classic 
sequential 
method bleeding before or on day ten is associated with endometrial 
proliferation and needs biopsy. A significant change in withdrawal 
bleeding prompts endometrial sampling. 
 
TRANSVAGINAL SONOGRAM 
 
Transvaginal sonogram may be an useful adjunct for evaluating 
patients with perimenopausal and postmenopausal uterine bleeding 
and selecting patients for additional testing. 
 
As the endometrial histology can be predicted with accuracy 
depending on the endometrial thickness and internal architecture of 
the endometrium, it actually become "Sono Microscopy" wherein 
structures that is not discernible with the naked eye can be 
appreciated. 
 
Normal anatomy of the corpus varies with age and parity. 
Length of uterus in various age groups are: 
 
Postpubertal   Reproductive 
 Postmenopausal 
5-6 cm    7 -8 cm   4-6 cm 
 
The echogenicity and thickness of the normal endometrium will 
vary depending on the phase of the menstrual cycle. 
 
The normal endometrial thickness during the various phases of 
the menstrual cycle and during the postmenopausal period are given 
in the following table. The thickness is measured in the long axis from 
basalis to contralateral basalis. The measurement should include only 
tissue and not fluid. 
 
Phase Thickness (mm) 
Menstrual 2-4 
Early proliferative 4-6 
Periovulatory 6-8 
Secretory 8-14 
Postmenopausal 4-8 
Postmenopausal with hormone 
replacement therapy 
4-10 
Tissue insufficient for diagnosis < 4-5 mm 
 
Not only the thickness, the echogenicity of the endometrium has 
certain specific characteristics during the various phases of the 
menstrual cycle, thus enabling the histology of the endometrium to be 
evaluated with precision by 
examining with transvaginal sonogram. 
 
During the menstrual phase - the endometrium appears as an 
echogenic uninterrupted layer of 1-4 mm in the total anteroposterior 
width. 
 
Grunfeld in 1991 has described three patterns in evaluating the 
changes in the normal endometrium. 
 
Follicular phase 
 
Pattern I : During the early proliferative phase the thickness is 2-4 
mm. Endometrium functionalis is hypoechoic or isoechoic and 
endometrium basalis is some what echogenic. 
 
Pattern II :  Ultrasound appearance of late follicular endometrium is 
characterised by three layers. Trilaminar appearance or triple sign. 
 
Middle layer represents the lumen of the endometrial cavity. The 
lumen is echogenic because the endometrium is coated with mucous 
that acts as an interface and reflects ultrasound. 
 
Surrounding the lumen is the hypoechoic endometrium 
functionalis and the echogenic endometrium basalis. There is increase 
in echogenicity from the basal layer upwards but the inner layer still 
has some hypoechogenic changes. 
 
The endometrium functionalis is hypoechoic in the follicular 
phase because of the homogenity of the odematous stroma and the 
lack of arteriole invasion. The basalis is always echogenic because of 
increased odema and vascularity of the basalis. In a normal cycle, the 
endometrial thickness ranges from 6.12 mm in the late follicular 
phase. Endometrium grows in the late proliferative phase at a rate of 
0.5 mm/day. 
 
The trilaminar appearance is characteristic of the peri ovulatory 
endometrium and was present in 92% of the late proliferative phase 
biopsies performed by Forrest et ai. Transmission of the ultrasound 
and posterior acoustic enhancement are also characteristic of 
follicular phase and is present in 90% of cases. 
 
 
Pattern III: In the secretory phase, the whole endometrium froin 
basalis to lumen is very echogenic. The increase in echogenicity, most 
probably is due to increase in luteal phase secretions and vascularity. 
The increase in echogenicity is seen due to the elevations of 
progesterone but may precede the rupture of follicle. Cul-de-sac fluid 
is often seen behind the uterus on ultrasound and helps to confirm 
that ovulation has occurred. The endometrium achieves its greatest 
width in the mid secretory phase measuring upto 14 mm in width. 
 
In postmenopausal patients the endometrial thickness is 
usually 4-8mm. The American college of Obstetrics and gynaecology 
has published a technical bullettin (No.215, November 1995) on 
gyaecologic ultrasound. This sets additional guidelines and 
expectations for transvaginal sonogram. 
 
Below a cutoff of 4-5 mm in the anteroposterior thickness of the 
endometrium for women with postmenopausal bleeding, there may 
not be significant associated pathology. Lessthan 4-5 mm or a thin 
pencil line echo is usually associated with tissue insufficient for 
diagnosis. 
 
Those more than 5 mm may need endometrial sampling. Thus 
transvaginal sonogram may be helpful in distinguishing patients with 
minimal endometrial tissue caused by postmenopausal atrophy and 
patients with significant amount of endometrial tissue or polyps and 
are in need of further evaluation. 
 
 
 
 
 
 
  
 
 
Pathologic conditions 
 
Recent studies with transvaginal ultrasound suggest that this 
modality may be of use in detecting endometrial abnormalities like 
polyps, endometritis, hyperplasia and carcinoma. 
 
Leiomyoma are seen as echodense defects within the 
myometrium. They are typically so dense that shadowing is apparent 
distal to the fibroid. Endovaginal sonography offers the opportunity to 
visualise the relationship of the fibroid to the endometrial cavity.  
 
Adenomyosis do not have clear borders and are less dense than 
leiomyoma. They do not shadow like fibroids and are commonly cystic. 
They are seen as mottling within the myometrium. They may present 
as a myometrial mass or if the glands begin secreting as cystic 
structures within 
the inner myometrium. 
 
Endometrial filling defects - endometrial polyps are seen as 
endometrial filling defects. Scanning for endometrial contour defects 
should be done in the follicular - phase because the hypoechoic 
endometrium serves to contrast against echogenic masses. The 
presence of a filling defect is 70% sensitive and 95% specific when 
compared with hysterosalphingo gram (Blumen feld and Turner 1996). 
 
 
 
 
 
 In patients with endometrial carcinoma myometrial invasion can be 
determined. Loss of the subendometrial halo, consisting of compact 
nyometrium is the first ultrasonographic feature of invasion seen 
lonographically. With more advanced myometrial invasion a distinct 
tumor – myometrial interface can be visualised. Schoenfeld et al 
measured invasion from the endometrial lumen to the most distant 
tumor interface. This measurement divided by the total thickness of 
the uterine myometrium (or). Total anteroposterior uterine distance is 
divided by the total endometrial width. If this ratio exceeds 30%, 
myometrial invasion is suspected.  
 
According to the latest FIGO classification the depth of 
myometrial invasion distinguishes stage IB of endometrial carcinoma' 
from stage IC. Gordon et al determined preoperative assessment of 
myometrial invasion by 
transvaginal sonogram in a group of 25 patients with histologically 
proven endometrial cancer and found that in 84% of cases, 
transvaginal sonogram correctly predicted the depth of myometrial 
invasion within 15% of the actual measurement. 
 
Transvaginal sonogram was accurate in 16 cases over diagnosis 
in 3 cases. Therefore sensitivity of transvaginal sonogram in detecting 
deep invasion was 100%. Specificity morethan 80%, accuracy 84%.  
 
 
  
 
Cacciatore et al used preoperative ultrasonogram to stage 93 patient 
with endometrial cancer and were able to predict correctly myometrial 
invasion in 80%. Songraphic staging was accurate in 90% of cases. 
 
Endometrial volume: An endometrial. volume can be calculated by 
multiplying its length by long axis, with anteroposterior and 
transverse dimensions. This determination has clinical application in 
the prediction of the amount of decidua or abnormal endometrial 
tissue that is present and can be removed by dilation and curettage. 
 
Ovarian volume: Premenopausal ovarian volume is influenced by the 
stage of the menstrual cycle. 
 
Preovulatory volume is 5.1 - 6.2 cm3 
Postovulatory volume is   3.2 + 1.7 cm3 
 
By applying the formula for a prolate ellipse ovarian volume is 
calculated by 
    π 
Ovarian volume  =       --- x Dl x D2 x D3 
    6  
 
Premenopausal ovaries on average measure 3.5 x  2.x 1.5 cm. 
 
Postmenepausal ovaries on average measure in 
 
Early menopause = 2 x 1.5 x 0.5 cm. 
Late menopause = 1.5 x 0.75 x 0.5 cm 
Trans vaginal sonogram allows accurate assessment of ovarian 
volume as well as intemal echotexture or morphology in these 
patients. Hence transvaginal sonogram enables early detection of 
ovarian cancer. 
Since long gynaecologists have felt the need for a simple safe 
noninvasive method which could be employed as a screening 
procedure for detecting endometrial abnormalities and neoplasia. A 
routine pap smear detects only 50% of cases with endometrial cancer.  
 
Curettage has long been considered to be the gold standard for 
the diagnosis of peri menopausal and postmenopausal uterine 
bleeding. It was first described by RecEmrier in 1843 for the removal 
of uterine fungosities. But dilatation and curettage has many 
shortcomings. 
 
Dilatation and curettage has a failure rate of 12-29% (Arthur et 
al). Stoch and Kanbour in a study of curettage before hystrectomy 
found that in 16% of specimen less than one fourth of the cavity was 
curetted, in 60% of specimens less than one half of the cavity was 
curetted. In 84% of specimens 
less than three - fourth of the cavity was effectively curetted. 
 
In 1970's various suction curettage devices were introduced 
which allowed sampling without anaesthesia in an office setting. In 
1974's Goldchmit et al performed pipelle aspiration biopsy in 135 
premenopausal patients before curettage. 10% had different histologic 
results on pipelle biopsy as compared with curettage. In 39% of 
patients, hyperplasia was missed. 3 of 5 polyps were missed, thus 
understanding the focal nature of the pathologic processes. 
 
Rodriguez et al did a pathologic study of 25 hystrectomy 
specimens. Pipelle's device sampled only 4% of the endometrial 
surface. Vabra aspirator sampled 41% of the endometrial surface. 
 
Guidoet al studied the specimens of 65 patients with known 
carcinoma undergoing hystrectomy. The surface area of endometrial 
cavity in volved by cancer in this study was less than 5% in 5% of 
patients, 5-25% of surface area was involved in 18% of patients, 26% - 
50% of the "surface area involved in 31% of patients and more than 
50% involved in 46% of patients. These results tell us a-great deal 
about the way endometrial carcinoma can be distributed over the 
endometrial surface or confined to a polyp. Thus tumors localised in a 
polyp or a small area of endometrium may go undetected by 
endometrial sampling or even with dilatation and curettage. Hence 
transvaginal sonogram can enhance the anatomic diagnosis and 
supplement the shortcomings of Dilatation and curettage. 
 
Procedure of transvaginal sonogram 
 
Until recently, the primary method for detecting gynaecologic 
pathology was bimanual pelvic examination, with confirmatory or 
additional information supplied by transabdominal ultrasound. 
 
Despite technical advances, transabdominal ultrasound imaging 
of the female reproductive tract was limited by attenuation of the 
sound beam by issues of the anterior abdominal wall, distended 
urinary bladder, precluding he use of high frequency transducers (5 
MHz) and the inability to correlate areas of visible pathology with 
direct palpation. Image resolution has improved dramatically with the 
introduction of transvaginal sonogram. The transducer is closer to the 
pelvic organs, so higher frequencies can be used, reducing attenuation 
of the sound beam resulting in improved overall image quality. 
Patient preparation 
 
Patient informed about the procedure. She is asked to empty 
her bladder completely. This contributes greatly to patient comfort 
and acceptance of this technique. The best position is the dorsal 
position employed for vaginal examination. A transabdominal 
sonogram is done prior to vaginal study to exclude large masses and if 
uterus is more than 10 cms as in such conditions, the vaginal study 
will be suboptimal due to its limited field of view. In all other cases, 
transvaginal sonogram can be performed in lieu of abdominal 
scanning. 
 
Transducer preparation 
 
Vaginal transducer are between 5-7.5 MHz in frequency. The 
size of the sector image is usually between 900 and 1150. The image 
is produced from an end firing transducer or a transducer that is 
angled upto 30° off axis. Focal zones range from 1-8 cm. The 
transducer should be covered by a condom filled with approximately 5 
ml of ultrasonic gel. Condoms that contain spermicidal agents should 
be avoided in cases of infertility.  
 
Additional gel may be applied to the outside of the condom prior 
to its insertion, but this should be omitted in cases of infertility. 
Following completion of examination, the transducer assembly should 
be immersed in disinfectant for ten minutes. 
 
 
 Probe manipulation 
 
Uterine corpus is an important structure in transvaginal 
sonogram and serves as a useful anatomical land mark for targeted 
organ imaging. Transducer orientation is unique in vaginal scanning, 
with the longitudinal (sagittal) plane directed from the patient's feet 
towards her head. Transverse scans are obtained in a coronal plane 
by rotating the transducer ninety degrees counterclockwise. Adnexa 
are optimally imaged by positioning the transducer somewhat 
obliquely towards the contralateral side of the pelvis. 
 
Confusion can also occur because the actual position of the 
ultrasound beam is 90° off axis from the image on the monitor. This 
results in the longitudinal images being displayed on the monitor in a 
ninety degree counter clockwise direction from their actual 
orientation.  
 
Ultrasound transducers have a reference mark. With the 
reference mark pointing up, left side of the screen represents a 
cephalad orientation and the top of the screen represents the anterior 
abdominal wall. With this view, an anteverted uterus points up and to 
the left whil~ a retroverted uterus points down and to the right. 
 
Anatomic changes due to scanning with an empty bladder must 
also be considered when performing vaginal ultrasound. The uterine 
fundus becomes much more anteverted. In addition the ovaries often 
change position following bladder decompression. 
  
Sliding test: It may be helpful to place one hand on the patient's 
lower abdomen while performing transvaginal sonogram in an effort to 
optimally position the ovaries in the transducer's field of view. Also 
areas of focal tenderness can be elicited with the movement of the 
transducer. Transvaginal sonogram can also be used in the followup 
of women on tamoxifen therapy for breast cancer and women on 
hormone replacemept therapy after menopause. 
AIM OF THE STUDY 
 
1. To determine the value of transvaginal sonography in detecting 
endometrial pathology especially endometrial polyps, 
myomatous polyps and abnormal endometrial architecture 
especially hyperplasias and endometrial carcinoma in 
perimenopausal an dpostmenopausal bleeding.  
 
2. To correlate the thickness of endometrium in patients with 
perimenopausal and postmenopausal bleeding with their 
histopathology reports and evaluate the technical and practical 
difficulties and diagnostic accuracy of the procedure.  
 
3. To correlate the endometrial volume as obtained by transvaginal 
sonogram in these women with postmenopausal bleeding with 
their histopathology reports. 
 
4. For accurate assessment of mean ovarian volume as well as its 
internal exhotexture and morphology in these women with 
postmenopausal bleeding. 
 
5. to determine the value of hysteroscopy in visualising the interior 
of uterus directly hysteroscopic guided biopsy gives more 
reliable and accurate diagnosis than doing blind dilatation and 
curettage. Also the addition of operative channel to the 
hysteroscope can be done as local therapeutic procedure. 
Improvements in instrumentation, optics and addition of 
operative capabilities, have led to a resurgence of in interest in 
hysteroscopy world wide.  
MATERIALS AND METHODS 
 
 
 This is a prospective study of 100 women carried out during the 
period 2005 - 2006 Fifty women with postmenopausal bleeding and 
fifty women with perimenopausal bleeding. 
 
Group A: Comprised of 50 women with postmenopausal bleeding. 
 
Selection criteria were:  
 
All patients were above the age of 40 years. 
All patients had attained menopause with amenorrhoea of one year 
duration 
Patients were not on any hormone replacement therapy. 
Clinically there was no mass perabdomen and on bimanual pelvic 
examination, uterus was found to be of normal size or atrophic and 
cervix was found to be healthy on speculum examination. 
Patients with cancer cervix, fibroid polyps which is visualised by 
speculum examination and adnexal swelling were excluded from this 
study. 
Group B: comprised of 50 perimenopausal women with abnormal 
uterine bleeding. 
 
Selection criteria were: 
 
The patients were all over 40 years of age  
Not yet attained menopause 
Uterus was normal size to 12 week size adnexa were clinically 
normal. On speculum examination cervix was healthy 
Cancer cervix and other benign pathological lesions of cervix 
were excluded. 
 
All the patients were from government Raja Sir Ramasamy 
Mudaliar lying - In Hospital Chennai. 
 
All these patients were subjected to transvaginal sonography 
prior to dilatation and curettage. 
 
Method 
 
A 7.5 MHz Elcot transvaginal sector probe with phased array 
and endfiring potential used.  
 
- All the patients were asked to empty their bladder prior to the 
examination. 
- The probe is covered with a sterile sheath or condom containing 
the acoustic gel 
The scan was performed with the patient in a supine position 
The transducer was introduced into the posterior vaginal fornix. 
 
The uterus was scanned in long axis and coronal views with 
special emphasis on endometrium. The scanning of the u~erus done 
first in the sagittal plane from fundus to the internal os. Regularity of 
the uterus noted. The length, anteroposterior measurements and 
transverse dimensions of the uterus were noted and endometrial 
volume calculated. 
 
Anteroposterior measurements of endometrial thickness were 
taken from basalis to contralateral basalis in the long axis of the 
endometrium. Oblique semi coronal views should be avoided as this 
may cause the endometrium to appear thicker. 
 
Uterine cavity examined systematically in both sagittal and 
coronal views for the presence of submucous fibroid polyps, 
endometrial polyps, adenomyosis or abnormal endometrial 
architecture.  
 
If there is suspicion of endometrial carcinoma, evidence and 
extent of myometrial invasion when present were noted. Now the 
probe angled to the right or left of midline in the sagittal plane to 
image the ovaries. The three dimension were measured and ovarian 
volume calculated. The internal echo   texture of the ovaries were also 
imaged and any abnormalities were noted. 
 
The entire pelvis was additionally examined to rule out any 
other pathology. 
 
The results of the transvaginal sonogram were interpreted as  
Normal endometrium 
Thickened endometrial echo or abnormal endometrial 
architecture 
Myomas 
Adenomyosis 
Polypoid lesions 
Pyometra 
Endometrial carcinoma 
 
 Dilatation and curettage was performed in all these patients as 
in-patient. Patients were taken to the operation theatre and placed in 
lithotomy position. The surgeon then performed antiseptic cleaning 
and draping. A routine pervaginal examination carried out. 
Endocervical curettings taken. Uterus was then sounded and its 
length noted. After serial dilatation of Cx, a blunt curette was 
introduced and all quadrants curetted thoroughly. The curettings sent 
for histopathological examination in formalin. The biopsy reports were 
studied.  
 
 About 5 cases in each perimenopausal & post menopausal 
group were underwent hysteroscopic guided direct visualization of 
uterine cavity and guided biopsy. 
 
Technique : 
 The patients is placed in lithotomy position. The positional of 
the uterus confirmed by bimanual examination. The cervix exposed 
with the help of a bivalve speculum, the cervix cleaned with saline and 
the external os cleaned with Betadine. The anterior lip of the cervix 
grasped and steadied with a vulsellum or tenaculum. A uterine sound 
passed to confirm the axis of the uterus, the cervix may be dilated to 
about 4 mm. The distension medium used here is Ringer’s lactate 
solution. 
 
Complications : 
 Infection, Perforation, Bleeding diatheses, Vascular 
hypotonicity, Allergic reations, Fluid overload and electrolyte 
disturbances, Gas embolism. 
 
 Endometrial pattern studied in transvaginal sonogram were 
correlated with histopathological reports. Almost all of these patient 
underwent hysterectomy either vaginal or abdominal.  
  
 
  
 
 
ANALYSIS AND OBSERVATIONS 
 
Table 1 : Comparison of histopathology with vaginosonographic 
measurement of endometrial thickness in Group A – 
Women with Post menopausal bleeding. 
 
No. Histopathology Report No. of Cases 
Mean endometrial 
thickness in mm 
Percen
tage 
1. Atrophic endometrium 18 3.87mm (2-5mm) 36% 
2. Tissue insufficient for 
diagnosis (TIFD) 
8 3.58mm (2.6-4mm) 16% 
3. Cystoglandular hyperplasia 7 13.57mm (11-
17mm) 
14% 
4. Nonsecretory endometrium  3 7mm (6-8mm) 6% 
5. Secretory endometrium 6 9.16mm (8-10mm) 12% 
6. Pyometra / Endometritis 4 9mm (8-11mm) 8% 
7. Endometrial carcinoma 4 17.2mm (16-18mm) 8% 
 
Note :  50% of women with Atrophic endometrium or TIFD had a 
mean endometrial thickness <5 mm and 50% of patients 
with endometrial pathology had a thickness > 5mm 
 
 
36% of women had atrophic endometrium with a mean 
endometrial thickness of 3.87mm. 16% of patients had tissue 
insufficient for diagnosis with a mean endometrial thickness of 
3.58mm. 
 
The incidence of endometrial hyperplasia was 14% with a mean 
endometrial thickness of 13.57mm. The incidence of nonsecretory 
endometrium was 6% with a mean endometrial thickness of 7mm. The 
incidence of secretory endometrium was 12% with a mean endometrial 
thickness of 9.16mm. In 4 cases of pyometra the mean endometrial 
thickness was 9mm. 8% of cases had endometrial carcinoma with a 
mean endometrial thickness of 17.2mm.  
 
Thus it can be seen that 50% of women with atrophic 
endometrium or tissue insufficient for diagnosis had a mean 
endometrial thickness less than 5 mm and 50% of patients with 
endometrial pathology namely proliferative phase, hyperplasia, 
carcinoma of the endometrium and pyometra had a mean endometrial 
thickness more than 5 mm. 
 
This is comparable with the following studies. 
i) Narsi and associates at St.Bartholomew’s hospital studies 111 
women with postmenopausal bleeding – results were published 
in obstetric and gynaecologic survey 1991. 
 
51 patients (45.9%) had normal ultrasound findings and 
endometrial thickness was 1-5mm. The remaining 54.1% of 
patients had an endometrial thickness of ≥ 6 mm. In 11 patients 
(10%) ultrasound was suggestive of hyperplasia. In 6 women 
ultrasound correctly predicte carcinoma of endometrium. In 16 
patients fibroids were diagnosed. Narsi et al suggested that an 
endometrial thickness of 5 mm or less is associated with 
endometrial atrophy and curettage is unnecessary in this group. 
 
ii) Mahlinova and pahlivanov conducted a prospective study of one 
hundred and eighteen patienst with postmenopausal bleeding. 
They compared transvaginal sonogram and endometrial 
thickness to histopathological reports in these women. 
(Published in the European Journal of obstetrics and 
gynaecology 1995 February). 
 
In 47.0% of women with histopathological diagnosis of atrophic 
endometrium the mean endometrial thickness was 3.1 ± 1.7 
mm whereas in the remaining 53% of women with endometrial 
abnormalities the endometrial thickness ranged from 10.2mm – 
26.8 mm. The mean endometrial thickness for patients with 
endometrial carcinoma was 18.4 ± 8.2 mm. 
 
No endometrial carcinoma was diagnosed in endometrial 
thickness less than or equal to 5 mm. The sensitivity was 100% and 
specificity 64% if a cut off of 5 mm was used.  
 
 
Table 2 : Comparison of ultrasonographic findings with 
histopathologic diagnosis of Dilatation and curettage and 
hysterectomy specimen in women with postmenopausal 
bleeding 
 
No. Ultrasonographic findings 
No. of 
Cases 
D&C – HPE 
report 
Hysterectomy HPE 
report 
1. Thin distinct pencil 
line echo ≤ 5 mm 
26 8-TIFD 
18-Atrophic 
endometrium 
6-Atrophic endometrium 
15-Atrophic endometrium 
5-Lost for followup 
2. Endometrial echo > 
5mm 
16 7- C.G.H. 
3-N.S.E. 
6-S.E. 
5 - C.G.H. 
2 - N.S.E. 
4 - S.E. 
5 – Lost for followup 
3. Fibroid 2 Not diagnosed 1 – Fibroid Antr. Wall 
2x2 cm seen in 
association with 
endometrial carcinoma  
2 – Ass. With C.G.H 
2x3cm Antr. Wall Fibroid 
4. Endometrial 
carcinoma 
4 4-Endometrial 
carcinoma 
4-well differentiated adeno 
Carcinoma Gr.I 
Myometrial invasion < 1/3 
5. Endometrial Polyp 2 1-atrophic 
endometrium 
1-N.S.E. 
Polyp not 
diagnosed 
1 - An endomentrial polyp 
1x1 cm seen N.S.E. 
1 - lost of followup 
6. Pyometra  4 Pus letout 
endometritis 
3 – Endometritis 
1 – Secretory 
endometrium 
 
TIFD : Tissue insufficient for diagnosis 
C.G.H : Cysto Glandular Hyperplasia 
N.S.E. : Non secretory endometirum 
S.E. : Secretory Endometrium 
D.C. : Dilatation & Curettage 
Note : The findings of the transvaginal sonogram correlated well with 
the final histopathologic diagnosis after hysterectomy giving a 
sensitivity and specificity of 100%. There were no false negative and 
false positive findings. D&C missed 2 fibroid polyps and 2 endometrial 
polyps. 
 In 25 patients transvaginal sonogram showed an endometrial 
thickness of ≤ 5 mm and the histopathology report after hysterectomy 
report was atrophic endometrium. Endometrial abnormality was 
suggested in the remaining twenty – five cases. In these twenty – five 
patients, there were 2 cases of fibroid, 2 cases of endometrial polyp, 4 
cases of endometrial carcinoma 4 cases of pyometra, 16 cases with 
endometrial echo > 5 mm were associated with endometrial 
hyperplasia including one case with atypical hyperplasia. All these 
patients underwent hysterectomy and the histopathology findings of 
the hysterectomy specimen correlated well with the findings of 
transvaginal sonogram giving a sensitivity and specificity of 100%. 
 
 The findings of the present study are comparable with that of 
the following studies (i) Dubinsky TJ, Parvey HR and Maklad N has 
evaluated the role of transvaginal sonography and endometrial biopsy 
in the evaluation of postmenopausal bleeding published in the 
American Journal of Roentgenology 1996 July. 
 
 They have evaluated the reliability of TVS in diagnosing 
intrauterine disease by comparing it with hysterectomy specimen. 
 
In 259 women transvaginal sonogram was done. The findings 
were endometrial thickness ≤ 5 mm 107 women (40%) 
Endometrial thickness > 5 mm 39 (20%) 
Enlarged uterus 64 
Endometrial carcinoma 18 patients 
 
 Final pathologic diagnosis was 
Atrophic endometrium 107 
Endometrial hyperplasia 39 
Endometrial carcinoma 18 
of the women with Enlarged uterus 
57 - had fibroids 
3 - Adenomyosis  
4 – Sarcoma 
 
In their study the correlation between transvaginal sonogram and 
histopathological report of hystrectomy specimen was very good giving a 
sensitivity of 96%, and specificity of 86%, positive predictive value 91% 
and negative predictive value 94%). 
 
(ii) Alkazar and Laparte in their study of transvaginal sonogram in 
28 women with postmenopausal bleeding found that 14 patients had 
normal sonogram with an endometrial thickness $ 5 mm and 14 patients 
had endometrial thickness ≥ 5 rom with endometrial abnormalities. All 
these patients underwent hystrectomy and findings correlated with a 
transvaginal sonogram giving sensitivity 100% specificity 100% positive 
predictive value 100% and negative predictive value 100%. 
Table 3 : Comparison of histopathology with vaginosonographic 
measurement of endometrial volume in Group A – women with 
postmenopausal bleeding.  
 
No. Histopathology Report No. of Cases 
Mean endometrial 
volume cm3 
Percen
tage 
1. Atrophic endometrium 18 12.72 (8.46-14.20 
cm3) 
36% 
2. Tissue insufficient for 
diagnosis  
8 11.50 (10.45-12.46 
cm3) 
16% 
3. Cystoglandular hyperplasia 7 59.34 (28.86-95.70 
cm3) 
14% 
4. Nonsecretory endometrium  3 43.87 (43.16-45.3 
cm3) 
6% 
5. Secretory endometrium 6 48.78(34.61-63.40 
cm3) 
12% 
6. Pyometra / Endometritis 4 49.33 (26.8-68.54 
cm3) 
8% 
7. Endometrial carcinoma 4 136.03 (102.8-
175.84 cm3) 
8% 
 Total 50   
 
Note :  When the mean endometrial volume was < 13 cm3 the 
histopathological report is atrophic endometrium. An 
endometrial volume > 13 cm3 is associated with 
endometrial pathology. 
 
 Campbell, Savvos and Tailor in the year 1996 October had 
analysed the endometrial volume in 103 patients with 
postmenopausal bleeding not on hormone replacement therapy. 71 
patients (69%) with atrophic endoemtrium had a mean endometrial 
volume 5.47 cm3, 8 cases with endometrial hyperplasia and 
endometrial polyps had a mean endometrial volume of 39 cm3 and 
10.8% of patients with endometrial cancer had a mean endometrial 
volume of 69 cm3. 
 
 Hence they concluded that with the cutoff value of the 
endometrial volume of 13cm3 (i.e.) when the endometrial volume was 
less than 13cm3 the histopatholoy report was that of atrophic 
endometrium (69%). When the endometrial volume was more than 
13cm3, the histopathology report of curettage was found to be active 
endometrium.  
 In the present study, the mean endometrial volume with 
Atrophic endometrium was 12.72cm3, with tissue insufficient for 
diagnosis was 11.50cm3. In women with endometrial hyperplasia the 
mean volume was 59.34cm3. With nonsecretory endometrium the 
mean endometrial volume of 43.87cm3, and withsecretory 
endometrium the mean endometrial volume of 48.78cm3. With 
pymetra the mean endometrial volume was 49.33cm3. 
 Hence from this study it is seen that with endometrial volume 
less than 13.0cm3 the histopathology report has come as atrophic 
endometrium or tissue insufficient for diagnosis. If the endometrial 
volume is more than 13.0cm3, the histopathological report is that of 
active endometrium. But this study needs still further evaluation 
before it can be applied in practice. 
  
Table 4 : Comparison of ovarian volume calculated by 
ultrasonogram with the histopathology report of the 
hysterectomy specimen Group A women with 
postmenopausal bleeding. 
 
 
 
No. Postmenopausal ovarian volume 
No. of 
Patie
ents  
Mean Ovarian 
volume 
Comparison with 
pathology reports 
after 
hysterectomy 
1. Normal ovarian 
volume 
48 2.58 cm3 
(1.1cm3-4.8cm3) 
All of uniform 
internal 
exhotexture 
All ovaries atrophic 
/ normal 
2. Cystic ovaries 
with uniform 
echotexture 
2 6.45cm3  
(2.3-10.34cm3) 
echotexture 
Follicular cyst 
3. Suspicious of 
malignancy 
- - - 
 
 
 The mean postmenopausal ovarian volume was found to 2.58 
cm3 with a range of 1.1-4.8cm3. After hysterectomy the 
distopathological report of al these patients were atrophic or normal 
ovaries. No other pathology were detected, giving a sensitivity and 
specificity of 100%. These results were comparable with that of the 
following studies. 
 
 Higgins et al determined mean normal postmenopausal ovarian 
volumes to be 2.9cm3 but with a very wide range of 0.4-7-8cm3 
(gynaecologic oncology 1989). 
 
 Goswamy, Campbell and Rovston JP et al published an article 
on the ovarian volume in postmenopausal women (British Journal of 
obstetrics and gynaecology 1988). 
 
 They calculated the ovarian volumes on 2246 postmenopausal 
women and found the right ovarian volume to average 3.58cm3 (Range 
0.8-10.9cm3) and left ovarian volume to average 3.57cm3 (range 0.88-
10.9cm3). 
 
Group B : 50 women with perimenopausal bleeding. 
Table 5 : Comparison of Histopathology with vaginosonographic 
measurement of endometrial thickness. Group B - 
women with Perimenopausal bleeding. 
 
No. Histopathology Report No. of Cases 
Mean endometrial 
thickness in (mm) 
Percen
tage 
1. Nonsecretory endometrium 26 8.73 (6-11) 52% 
2. Secretory endometrium 4 10.25 (9-12) 8% 
3. Proliferative Endometrium 4 8.75 (8-10) 8% 
4. Cystoglandular hyperplasia 11 15.36 (13-18) 22% 
5. Adenomatous hyperplasia 1 22mm 2% 
6. Atypical hyperlasia 1 24mm 2% 
7. Endometritis 1 18mm 2% 
8. Endometrial carcinoma 3 25.5 mm (25-28) 4% 
 Total 50   
 
Note : With an endometrial thickening ≤ 13 mm the 
histopathology report is normal endometrium. When the 
endometrial thickening ≥ 13 mm the histopathology report 
is hyperplasia/carcinoma.  
 In this group, those with a nonsecretory endometrium have a 
mean endometrial thickness of 8.73mm, secretory endometrium of 
10.25mm, with cystoglandular hyperplasia of 15.36mm, with 
adenomatous hyperplasia the thickness was 22mm, with atypical 
hyperplasia was 24 mm, with endometritis 18 mm and with 2 cases of 
endometrial carcinoma it was 25.5mm.  
 
 34 cases (68%) of women with perimenopausal bleeding had 
normal endometrium by transvaginal sonogram and had a mean 
endometrial thickness of 9.29 mm with a range of 6-12 mm. For all 
these patients the histopathological report was either nonsecretory or 
secretory endometrium. 
 
 In the remaining 16 cases (32%) with endometrial abnormality, 
the endometrial thickness was found to range from 13 mm in a case 
with cystoglandular hyperplasia to 24mm for Atypical hyperplasia to 
25.5. mm for a case with endometrial carcinoma. 
 
 Therefore it can be seen that below an endometrial stripe 
thickening less than 13 mm the histopathology report was normal 
endometrium either secretory or nonsecretory. An endometrial stripe 
thickening more than are equal to 13mm has been found to be 
associated with hyperplasia including one adenomatous and one 
atypical hyperplasia. 
 
 The results of this present study are compared with the results 
of the following study.  
 
 
(i) Emmanuel, Mark, Marion, Verdel and Lammes in the American 
Journal of Obstetrics and gynaecology have determined the 
diagnostic value of transvaginal sonogram for endometrial and 
intrauterine abnormalities in women with perimenopausal 
bleeding. 
 
279 consecutive perimenopausal women with abnormal uterine 
bleeding were subjected to transvaginal sonogram. Though a cut 
off value for endometrial thickness in premenopausal patients is 
not available in the literature, they have found that in their 
study population a cut off level of 12 mm for normal 
premenopausal endometrium was adequate with no false 
negative or false positive results. 
 
135 patients with normal sonogram were confirmed to be true 
negative by histopathological examination. The mean thickness 
of the endometrium was 5.8 ± 2.8 mm (range 1-12). Abnormal 
sonograms found in 121 patients had a mean thickness 14.3 ± 
2.3 mm (range 13 20). The "thinnest" endometrial hyperplasia 
was found to be 13 mm. With these findings a cut off level of 12 
mm was found to be adequate in this study population with a 
sensitivity and specifity of 100%  
 
(ii) Towbin, Gnazda and March published in the American Journal 
of obstetrics and gynaecology June 1996, examined 131 
patients with perimenopausal bleeding by transvaginal 
sonogram. As the maximum thickness of the endometrium is 14 
mm an endometrial echo complex is considered thickened if it is 
more than or equal to 15 mm. 
They have found that a thickened endometrial stripe ≥ 15 mm is 
a better predictor of intracavitary pathologic disorders in the 
follicular phase than in the luteal phase. 59 patients had a 
normal sonogram with endometrial stripe ≤ 15 mm. Rest of the 
patients had endometrial stripe ≥ 15 mm. Of these 6 patients 
with endometrial stripe ≥ 15 mm with no other structural 
abnormalities were found to have hyperplasia of endometrium. 
52 patients had ultrasonography results consistent with 
leiomyomas 11 had thickened uterine wall and 2 had polypoid 
lesion. No case of endometrial carcinoma was reported.  
 
Hence they have suggested that a thick endometrial echo 
complex in the follicular phase ≥ 15 mm correlates strongly with the 
presence of intracavitary pathologic disorders and endometrial 
abnormalities. 
 
The results of this study are found to be comparable with that of 
the present study. 
Table 6 : Comparison of transvaginal sonographic findings with 
histopathologic diagnosis of dilatation and curettage and hysterectomy 
in women with perimenopausal bleeding 
No Ultrasono graphic findings 
No. 
of 
Cas
es 
D&C – HPE report Hysterectomy HPE report 
1. Normal 
endometrium 
endometrial 
thickness ≤ 13 
mm 
23 18- N.S.E. 
2 – S.E. 
3 – Proliferative 
18- N.S.E. 
2 – S.E. 
3 – Proliferative 
2. Endometrial 
stripe thickened 
≥ 13 mm 
13 11 – C.G.H 
1 – Adenomatous 
hyperplasia 
1 – Atypical 
hyperplasia 
11 – C.G.H 
1 – Adenomatous 
hyperplasia 
1 – Atypical 
hyperplasia 
3. Adenomyosis 7 3 – N.S.E 
2 – C.G.H. 
2 – Secretory 
Endometrium 
7 – Adenomyosis 
4. Myomatous 
polyp 
4 2 – N.S.E 
1 – Proliferative 
1 – Atypical 
Hyperplasia 
4 - Myomatous polyp 
5. Endometrial 
polyp 
1 1 – N.S.E. 1 – endometrial 
polyp 
6. Endometrial 
carcinoma 
suspsected due 
to  abnormal 
thick endometrial 
stripe 25mm. 
Loss of 
subendometrial 
halo. And with 
myometrial 
invasion 
2 2 - Adeno 
carcinoma  
1 – Adenocarcinoma 
of endometrium well 
differentiated Gr. I 
myometrial invasion 
< 1/3  
1 – Lost for followup 
7. Endometritis 1 Endometritis Endometritis 
Note : Findings of transvaginal sonogram correlated well with 
histopathological report after hysterectomy. 7 cases of adenomyosis, 4 
cases of myomatous polyp and 1 case of endometrial polyp were 
missed by dilatation and curettage.  
 Out of 50 perimenopausal patients, 23 had normal 
endometrium both by transvaginal sonogram and hysterectomy 
specimen. 13 cases with endometrial thickness > 15 mm and no other 
abnormal intracavitary pathology were found indeed to have 
endometrial hyperplasia as per hysterectomy specimen. 7 cases of 
adenomyosis, 4 cases of myomatous polyp and 1 case of endometrial 
polyp were all diagnosed by transvaginal sonogram which correlated 
well with the pathological diagnosis after hysterectomy giving a 
sensitivity of 100%, specificity 100%, positive predictive value 100% 
and negative predictive value 100%. 
 
 This compared with the following studies. 
 
i) March and Tombin evaluated 149 consecutive patients with 
perimenopausal bleeding by transvaginal sonography and the findings 
were compared with specimen obtained from hysterectomy used to 
represent the true diagnosis. The findings after transvaginal sonogram 
was normal sonogram in 59 patients, intramural myoma 52 patient, 
thickened uterine wall 11, polypoid lesion 2 patients. The final 
pathological diagnosis after hysterectomy was hyperplasia 6 patients, 
adenomyosis 11 patients, myoma 52 patiens, polyps in 72 patients 
and normal in 7 patients. It is seen that myomas and Adenomyosis 
correlated well with the final pathological diagnosis 15 edometrial 
polyps were missed by transvaginal sogoram. Normal pathology was 
seen only in 7 patients all these giving a  sensitivity of 54%, specificity  
90%. They concluded that the limiting factory with transvaginal 
sonogram is the high frequency of" equivocal" scans. 
 
(ii) Emmanual et al in their analysis of 279 women with 
perimenopausal bleeding subjected to transvaginal sonogram 
and compared with final pathological diagnosis at hystrectomy. 
They found that 135 patients with normal sonogram when 
compared with final pathological diagnosis endometrial polyps 
were not visualised in 4 premenopausal patients marked by very 
hyperechodense late secretory endometrium. These would have 
been visualised well if carried out during proliferative phase. 54 
submucous myomas were diagnosed correctly. 5 endometrial 
hyperplasia diagnosed correctly. 6 women with endometrial 
carcinoma diagnosed correctly. Transvaginal sonogram was in 
conclusive in 19 women giving 96% sen~itivity, specificity 61% 
and positive predictive value 39%. 
 
Table 7 : Comparison of ovarian volume calculated by vaginal 
ultrasonogram with hisopathological report of hysterectomy 
specimen in women with premenopausal bleeding 
 
No. Ultrasonographic findings 
No. of 
cases 
Mean Ovarian 
volume 
Histopathology 
report 
1. Normal ovarian 
volume 
43 3.8 cm3  (2.3-8.4cm3)  All were normal 
2. Cystic ovaries with 
uniform 
echotexture 
7 10.8cm3 (6.2-13.86) Follicular cysts no 
evidence of 
malignancy 
3. Suspicious of 
malignancy 
- Nil Nil 
 
 Granberg Wikland et al in the journal of ultrasound medicne 
1987 measured ovarian volume in about 806 premenopausal women 
found that the permenopausal ovarian volume is influenced by the 
stage of the menstrual cycle. Preovulatory volume varies between 5.1 
and 6.2cm3 while the postovulatory volume averages about 3.1 ± 1.7 
cm3. 
 
 In this present study in 86% the mean ovarian volume was 
normal and found to be 3.8 cm3 (2.3-8.4cm3). All these were found to 
be normal after hysterctomy. In 14% of women the ovaries were found 
to be uniformly cystic with normal echotexture with a mean ovarian 
volume of 10.8cm3 (6.2-13.86cm3). The pathological diagnosis is 
follicular cysts. No evidence of malignancy seen.  
Diagnostic Hysteroscopy 
 
Table 8 : Comparison of Hysteroscopic guided biopsy with 
Transvaginal ultrasonogram and hysterctomy 
specimen in perimenopausal and postmenopausal 
bleeding. 
 
I. Perimenopausal Bleeding : 
No. Ultrasonographic findings 
No. of 
cases 
Hysteroscopic 
diagnosis  
Hysterectomy 
histopathology 
report 
1. Endometrial polyp 1 1 Lost for followup 
2. Submucosal 
myomatus polyp  
1 1 Lost for followup 
3. Adenomyosis 1 1 Adenomyosis 
4. Endocerival polyp 1 1 Endocerival polyp 
5. Normal endometrium 1 1 Normal endometrium 
 Total 5   
 
II. Postmenopausal Bleeding : 
No. Ultrasonographic findings 
No. of 
cases 
Hysterosc
opic 
diagnosis  
Hysterectomy 
histopathology 
report 
1. Atrophic endometrium 3 3 3-Atrophic 
endometrium 
2. Endometritis 1 1 Lost for followup 
3. Submucosal myomatus 
polyp 
1 1 1-Submucosal 
myomatus polyp 
 Total 5   
 
 Instead of doing blind procedure of dilatation and curettage 
hysteroscopic guided biopsy and direct visualization of uterine cavity 
gives more accuracy in taking specimen and diagnosis. It is well 
correlated with hysterectomy specimen and Transvaginal 
ultrasonogram.  
 
 
 
  
 

DISCUSSION 
 
 In the group with postmenopausal bleeding the thickness of 
endometrium ranged from 2mm in a woman with atrophic 
endometrium to 18 mm in a woman with well differentiated stage I 
endometrial carcinoma. 
 
 The percentage of carcinoma endometrium was 8 and the 
percentage of endometrial hyperplasia 14%.  50% of women were 
found to have an atrophic endometrium or tissue insufficient for 
diagnosis. 
 
 Of 50 women with normal sized uterus on examination 2 
myomatous polyps, 2 endometrial polyps and 4 cases of pyometra 
were diagnosed by ultrasonogram. These findings correlated with 
pathological diagnosis after hysterectomy. 
 
 A transvaginal ultrasound measured endometrial thickness of 5 
mm and less was associated with an atrophic or in active 
endometrium or tissue insufficient for diagnosis in the 
histopathological report. 
 
 Endometrial pathology and abnormalities were found only 
among those women whose endometrial thickness was greater than 5 
mm. 
 Various studies have been conducted in the last five years and 
the results of some are compared with the present study.  
  
 
 
 
 
Table 8: Endometrial thickness as m,easured by endovaginal 
sonography for identifying endometrial abnormality in 
women with postmenopausal bleeding. A comparison of 
various study groups 
 
Study group No. of 
patients 
Cut of
point 
mm 
Specificity
% 
Sensitivity 
% 
PPV
% 
NPV
% 
Granberg et al 205 6 96 100 87.3 100 
Goldstein et al 500 5   35 100 
Osmer et al 155 4 81 89   
Schmitt et al 135 5 98.2 100   
Vanden Bosch 
et al 
140 4mm 98.0 80.0 76.7 84.8
Dorum & 
Colleagues 
50 6mm 80 60 26 94.4
Present study 100 5mm 100 100 100 100 
 
 
 
 
The purpose of the study of Granberg et al was to evaluate 
endometrial thickness as the only parameter for excluding endometrial 
abnormalities. In this study no endometrial abnormality was found if the 
endometrium was < 6 mm thick. This was in agreement with N asari and 
Coast, as well as Fleischer et al. In this study 70% of the curettage could 
have been avoided if the 5 mm limit had been used.  
 
Goldstein et al in their study of 500 postmenopausal women with 
bleeding reported that endometrial thickness of less than 5 mm is 
uniformly associated with minimal tissue obtained by sampling or an 
atrophic endometrium. They had one malignancy in this series. They 
described it as a 
very sensitive but not a very specific technique. 
 
Osmers et al in a prospective pilot study of 155 postmenopausal 
women not on hormone replacement therapy reported that an 
endometrium of > 4 mm was associated with abnormality. They found 
vaginal sonography to be a highly specific and sensitive method for the 
detection of endometrial pathology. 
 
Van den Bosch et al in their analysis of one hundred and forty, 
consecutive postmenopausal women found that the sensitivity of vaginal 
ultrasonography for endometrial disease was 98.2 if 4 mm was used as 
the cut off point for endometrial thickness. 
 
In the present study of 50 women with postmenopausal 
bleeding using 5 mm as a cut offlimit, vaginal sonography successfully 
diagnosed endometrial abnormality. The specificity and sensitivity 
were both 100%. There were no false negative or false positive with a 
positive predictive value of 100% and negative predictive value of 
100%. 
  The endometrial volume in women with postmenopausal 
bleeding ranged from 8.46cm3 in atrophic endometrium to 175.84cm3 
in a patient with endometrial carcinoma. Less than 13 cm3 was 
associated with an atrophic or inactive endometrium and more than 
13cm3 was associated with endometrial pathology. 
 
 The mean ovarian volume in women with postmenopausal 
bleeding was found to be 2.58cm3 (1.1 – 4.8cm3). The findings were 
found to correlate well with hysterectomy specimen.  
 
 
Group B Women with perimenopausal bleeding 
 
 In women with perimenopausal bleeding the percentage of 
endometrial carcinoma was 4%, the percentage of endometrial 
hyperplasia was 26%, the percentage of women with adenomyosis was 
14% myoma uterus 8% and 2% of women had endometrial polyps of 
2% had endometritis. 
 
 In 50 women with normal pelvic examination adenomyosis was 
diagnosed in 7 cases, myoma was dignosed in 4 cases and 
endometrial polyp diagnosed in 1 case. Endometrial carcinoma was 
correctly diagnosed in 2 cases. The ultrasonographic findins 
correlated well with the pathological report of the hysterectomy 
specimen giving a sensitivity and specificity of 100% with no false 
positive or false negatives. Dilatation and curettage missed the 
diagnosis of adenomyosis, myomatous polyp and endometrial polyps. 
 
 In this study 68% of women with normal endometrium had an 
endometrial thickness of less than 13mm below which there was no 
endometrial pathology. Above this cut off level of 13mm were found to 
associated with endometrial pathology. The sensitivity and specificity 
was found to be 100%. There were no false positive or false negatives.  
 
 
 
  
 
 
Table 9 : Endometrial thickness as measured by endovaginal 
sonography for identifying endometrial abnormality in 
women with perimenopausal bleeding – A comparison 
of various study groups  
 
 
Study Group No. of patients 
Cut 
off 
points 
(mm) 
Sensit
ivity 
% 
Specifi
city % 
PPV 
% 
NPV 
% 
Towbin, March 
et al 
131 15 
mm 
100 86 91.7 94 
Emmanuel et al 279 12 
mm 
79 93 - - 
Present study 50 13 
mm 
100 100 100 100 
 
 
(i) Towbin, March et al had found that in their analysis of 131 
patients with perimenopausal bleeding, a thick endometrial 
stripe of ≥ 15 mm were found to correlate strongly with the 
presence of intrauterine pathology and endometrial 
abnormalities. Sensitivity 100%, specificity 86%, positive 
predictive value 91.7% and negative predictive value 94%. 
 
(ii) Emmanuel, Mark, et al in the year 1995 in their analysis of 279 
women with perimenopausal bleeding have found a cut off value 
of 12 mm for endometrial thickness below which the report was 
normal endometrium and above which it was associated with 
endometrial pathology. 
 
Emmanuvel et al have also stated that though in the literature, 
normal cutoff levels for premenopausal endometrial thickness 
were not available, he concludes from his study that such a 
cutoff level can be assigned to the premenopausal patients for 
exclusion of endometrial abnormalities as is available in 
postmenopausal patients. 
 
The normal mean premenopausal ovarian volume was found to 
be 3.8cm3 (2.3-6.4cm3). 7% of ovaries were found to be cystic with 
normal internal echotexture and the findings were found to correlate 
well with hysterectomy specimen.  
  
  
  
 
SUMMARY 
 
1. Study consist of 100 patients, 50 patients with perimenopausal 
bleeding and 50 patients with postmenopausal bleeding. 
 
2. In women with postmenopausal bleeding, when the endometrial 
thickness ≤ 5 mm in transvaginal sonogram the 
histopathological report was atrophic endometrium. When the 
endometrial thickness was more than 5 mm it was associated 
with endometrial pathology. The sensitivity and specificity of 
this cut off value was 100% and there were no false negatives or 
false positive giving a positive predictive value of 100% and 
negative predictive value of 100%. 
 
3. In women with perimenopausal bleeding, when the endometrial 
thickness was ≤ 13mm in transvaginal sonogram, the 
histopathological report was proliferative or secretory 
endometrium and no endometrial hyperplasia or carcinoma 
were reported. When the endometrial thickness was ≥ 13 mm 
the report was endometrial hyperplasia or carcinoma. There 
were no false negatives or false positives giving a sensitivity 
100% specificity 100%. 
 
4. In women with postmenopausal bleeding, a mean endometrial 
volume of ≤ 13cm3 was associated with atrophic endometrium 
and no endometrial pathology was reported. When the mean 
endometrial volume of ≥ 13cm3, it was associated with 
endometrial pathology.  
 
5. The mean ovarian volume in women with postmenopausal 
bleeding was found to be 2.58cm3 with a range of 1.1-4.8cm3. 
The histopathological diagnosis after hysterectomy was normal 
or atrophic ovaries. Transvaginal sonogram has a 100% 
sensitivity and 100% specificity in assessing eh ovarian volume 
in postmenopausal women. There were no false negatives or 
false positives. 
 
6. In both groups of women with perimenopausal and 
postmenopausal bleedings, intrauterine abnormalities of 
endometrium and myometrium as adenomyosis, myomatous 
polyps and endometrial polyps were diagnosed with 100% 
sensitivity and 100% specificity as per correlation with 
pathological diagnosis of the hysterectomy specimen. 
 
7. Cases with endometrial adenocarcinoma were diagnosed with 
precision by transvaginal sonogram and myometrial invasion 
was also predicted. 
 
8. In women with perimenopausal bleeding, transvaginal sonogram 
picked up 7 cases of Adenomyosis, 4 cases of myomatous polyps 
and 1 case of endometrial polyp which were missed by dilatation 
and curettage. 
 
9. In women with postmenopausal bleeding transvaginal sonogram 
picked up 2 cases of myomatous polyps and 1 case of 
endometrial polyps which were missed by dilatation and 
curettage.  
 
10. About 10 cases studied with hysteroscopic visualisation of 
uterine cavity and hysteroscopic guided biopsy which gives 
more reliable and accurate diagnosis than doing blind D&C. 
Also it is used as local therapeutic procedure.  
 
CONCLUSION 
 
 Transvaginal sonogram is a simple, non-invasive convenient 
way to indirectly visualise the endometrial cavity. 
 
 The vaginal probe examination if incorporated into the 
gynaecology office setting and when combined with bimanual pelvic 
examination can enhance our anatomic diagnosis. 
 
 Transvaginal sonography is useful as a first step diagnostic 
procedure in the evaluation of peri and postmenopausal bleeding. 
  
 When combined with dilatation and curettage it can supplement 
the shortcomings of dilatation and curettage. 
 
 This study proves that this diagnostic tool correlates well with 
the histopathology findings. 
 
 Intrauterine pathology of the endometrium and myometrium 
were well delineated and endometrial carcinoma detected with 
precision. It can find out associated ovarian pathology.  
 
Instead of doing blind procedure of dilatation and curettage 
hysteroscopic guided biopsy and direct visualization of uterine cavity 
gives more accuracy in taking specimen and diagnosis. It is well 
correlated with hysterectomy specimen and Transvaginal 
ultrasonogram. 
  
 In future it appears that the ultrasonogram will continue to take 
the role of a stethoscope for the gynaecologist. To be able to see the 
lining of the uterine cavity and the information obtained seems 
worthwhile.  
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GROUP A : WOMEN WITH POSTMENOPAUSAL BLEEDING 
Trans-vaginal Sonogram Findings 
Ovarian 
Volume 
Sl. 
No. Name I.P. No. 
P
r
o
v
i
s
i
o
n
a
l
 
D
i
a
g
n
o
s
i
s
 
Age, 
Parity 
Menopause 
associated 
risk factors 
Uterine size & 
associated findings 
(cms) 
Endom
etrial 
Volume 
(cm3) 
Lt Rt. 
Endometr
ial 
Thickness 
(mm) 
Histopathology Report 
1. Kannammal 
9779 
PMB 65,P5L5 8 yrs 4.2x2.7x1,3 12.15 3.2 1.6 3 D&C  Atrophic  
H  Endometrium 
2. Muniammal 
1138 
PMB 56, P4L4 2 yrs back 7.2x4.2x3 R. ovary 
cystic normal 
echotexture 
70.53 2.3 8.6 14 D&C  cystoglandular  
H  Hyperplasia  
3. Venkatamma 
1769 
PMB 50, P3L2 1 yr back 5.4x3.2x3 45.98 4.2 2.8 8 D&C  Secretory 
H  Endometrium 
4. Egavalli 
5077 
PMB 55, P4L4 2 yrs back 3.4x2.3x1.4 
Endometrial polyp 
1x1.5cm 
10.56 1.6 1.5 4 D&C  Atrophic 
H  Endometrium 
5. Anjalai 
6916 
PMB 65, P4L3 10 yrs 
back 
3.6x1.7x1.6 8.46 2.0 2.4 6 D&C  Atrophic 
H  Endometrium 
6. Nayagam 
1047 
PMB 50, P3L3 3 yrs back 3x2.6x1.4 11.6 2.3 1.8 4 pencil-
line Echo 
D&C  TIFD 
H  Atrophic Endometrium 
7. Ellammal  
1438 
PMB 60, P2L2 3 yrs back 5x4.2x4 pyometra 56.43 3.4 3.6 11 D&C  pus poured out 
H  Endometritis 
8. Kanniammal 
1732 
PMB 52, P2L2 
DM 
2 yrs back 4.2x2.6x1.6 12.46 2.8 1.8 3 pencil-
line Echo 
D&C  TIFD 
H  Atrophic endometrium 
9. Lalitha  
4424 
PMB 53, P3L3 4 yrs back 4.1x2.6x1.1 11.43 3.0 2.8 5 pencil-
line Echo 
D&C  Atrophic Endometrium  
H 
10. Nagarathinam  
674 
PMB 51, P4L4 3 yrs 7.5x4.3x2.5 76.06 4.02 3.5 12 D&C  Cystoglandular 
H  Hyperplasia 
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n a
l
 
D
Age, Menopause Trans-vaginal Sonogram Findings Histopathology Report 
Ovarian 
Volume 
No.   Parity associated 
risk factors Uterine size & 
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11. Sundari,  
681 
PMB 54, P3L3 4 yrs 5.3x2.4x1.2 14.2 3.6 2.7 4 pencil-
line Echo 
D&C  Atrophic 
H  Endometrium 
12. Mangalakshmi 
664 
PMB 52, P1L1 2 yrs 4x2.5x1.4 13.6 3.0 1.6 4 pencil-
line Echo 
D&C  Atrophic Endometrium 
H 
13. Chokkammal 
665 
PMB 64, P4L3 8 yrs 9.2x4.8x5.3 
Assymetrical 
thickening of 
endometrial echo 
loss of 
subendometrial halo 
with invasion of 
myometrium < one 
third. 
Break in uterine 
contous (R) corneal 
region. (L) side small 
hypoechoic lesion 
2x3cm 
 
175.84 2.8 3.5 16 D&C  Endometrial 
H  Adenocarcinoma 
 hysterectomy – 
 papillary 
 adenocarcinoma Gr.I. 
 myometrial invasion 
 less than one third 
 fibroid 2x3 cm in 
 anterior wall (L) side.  
14. Jayalakshmi 
2785 
PMB 64, P4L3 8 yrs 5.6x3.2x3.8 48.96 4.2 2.6 8 D&C Secretory 
H Endometrium 
15. Raji 
1639 
PMB 58, P2L2 3 yrs 4.8x2.8x1.8 10.6 3.2 2.4 4 D&C Atrophic Ednometrium  
H  
16. Alagammal 
4591 
PMB 
with 
white 
disch
arge 
58, P4L4 3 yrs 4.2x2.3x1.6 10.45 3.4 2.8 3 D&C TIFD 
H Atrophic Endometrium 
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n a
l
 
D
Age, Menopause Trans-vaginal Sonogram Findings Histopathology Report 
Ovarian 
Volume 
No.   Parity associated 
risk factors Uterine size & 
associated findings 
(cms) 
Endom
etrial 
Volume 
(cm3) 
Lt Rt. 
Endometr
ial 
Thickness 
(mm) 
 
17. Chellammal 
6306 
PMB 63, P3L3 7 Yrs 6x3.4x2.6 pyometra 26.8 1.8 1.3 8  D&C pyometra 
H Endometritis 
18. Victoria 
3242 
PMB 52, P2 L2 
HT, DM 
3 yrs 5x3.4x2.6 41.4 3.4 2.8 11 D&C cytoglandular 
H hyperplasia 
19. Lakshmi  
1395 
PMB 59, P1L1 4 yrs 4.6x3.8x2.4 34.61 3.2 2.2 10 D&C Secretory endometrium 
H 
20. Savithiri  
4505 
PMB 57, P4L3 3 yrs 8.1x4x5.2 minimal 
obliteration 
subendometrial less 
than one third 
invasion 
 
120.24 1.8 2.7 17 D&C Adenocarcino 
 ednometrium 
H Well differentiated 
 Adenocarcinoma 
 Endometrium less than 
 one third myometrial 
 invasion tubes and 
 ovaries healthy.  
21. Devaki  
4896 
PMB 54, P3L3 2 yrs 3.8x2x1.3 12.28 2.6 2.2 4 pencil-
line Echo 
D&C TIFD 
H Atrophic Endometrium 
22. Rajapushpam 
781 
PMB 
 
58, P3L3 6 yrs 4.1x2.6x1.8 10.48 2.3 2.6 4 pencil-
line Echo 
D&C Atrophic Endometrium 
H 
23. Sakunthala 
858 
PMB 56, Nalli 
para 
2 yrs 3.6x2.9x1.2 14.16 2.3 1.8 3 pencil-
line Echo 
D&C Atrophic Endometrium 
H 
24. Fathima  
1094 
PMB 59, P2L1 4 yrs 5x4.2x3.1 13.16 2.2 2.4 5 D&C Atrophic Endometrium 
H 
25. Radhammal  
2068 
PMB 55, P3L3 3 yrs 6x4.8x2.4 11.48 2.6 1.6 4 D&C Atrophic Endometrium 
H 
26. Thulukkanam 
3061 
PMB 61, P2L2 9 yrs 4x2.8x1.6 12.16 2.1 1.4 4 D&C Atrophic Ednometrium 
H 
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n a
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27. Saraswathy  
4301 
PMB 63, P3L3 10 yrs 8x4.3x2.1 63.4 3.6 2.1 12 D&C Secretory Endometrium 
H 
28. Kamala  
4691 
PMB 
with 
white 
disch
arge 
70, P4L3 15 yrs 5.2x3.8x1.8 14.16 2.8 1.4 3 D&C Atrophic Endometrium 
H 
29. Kumari  
5392 
PMB 67, P4L4 12 yrs 4.1x3.2x2.5 10.84 2.6 1.2 4 D&C TIFD Atrophic 
H   Endometrium 
30. Rameeza Bee  
6046 
PMB 57, P3L3  7 yrs 7.4x5.6x4.5 
Myometrium less 
than one third 
invasion. Loss of 
subendometrial 
halo. 
145.24 4.5 2.6 18 D&C Well differentiated  
H adenocarcinoma 
 Adenocarcinoma -< 
 one third invasion 
 tubes and ovaries 
 normal  
31. Vasuki 
9126 
PMB 51, P2L2 3 yrs 5.8x3.6x2.8  
Hypoechoic lesion 
fibroid polyp 2x3cm 
within uterine cavity 
35.68 3.7 3.2 13 D&C Cystoglandular  
 Hyperplasia  
H Fibroid anterior wall  
 2x3 cm 
32. Kanga 
9426 
PMB 52, P2L2 2 yrs 4.8x3.4x1.2 13.46 2.1 1.6 2 D&C Atrophic Endometrium 
H 
33. Senthamarai 
9475 
PMB 56, P1L1 3 yrs 8x4.6x2.8 43.16 2.8 1.4 8 D&C Non-secretory  
H  enometrium 
34. Angammal  
9817 
 
PMB 59, P4L4 4 yrs 4x2.8x2.1 13.12 2.4 1.6 5 D&C Atrophic 
H Endometrium 
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35. Santhanamary 
9821 
PMB 
with 
white 
disch
arge 
62, P3L3 10 yrs 3.6x2.8x1.4 11.56 2.1 1.8 4 D&C  TIFD 
H Atrophic Endometrium 
36. Yasodha 7626  PMB 68, P5L4 15 yrs 6.8x3.6x3.4 
pyometra 
68.54 3.8 1.64 7 D&C Pus poured out 
 endometritis  
H Endometritis 
37. Devanbu  
1357 
PMB 60, P3L3 5 yrs 4.2x2.8x1.2 12.19 2.4 2 2.6 D&C TIFD 
H Atrophic Endometrium 
38. Vatchala  
3095 
PMB 52, P2L2 2 yrs 8.4x5.6x3 95.7 4.8 2.13 16 D&C Cystoglandular  
 hyperplasia 
H Adenomyosis 
39. Kasthuri 
2742 
PMB 50, P2L2 1 yr. 5x3.8x2.3 
endometrial polyp 
1x2 cm 
45.3 2.6 1.7 7 D&C Non-secretory 
H Endometrium 
40. Saroja 
1658 
PMB 53, P3L3 2 yrs 3.8x2.1x1.2 11.08 2.3 1.1 2.8 D&C Atrophic 
H Endometrium 
41. Ranganayagi  
1049 
PMB 50, Nalli 
Para, HT 
4 yrs 9x6.2x4.1 
Myometrium less 
than one third 
invasion. Loss of 
subendometrial 
halo. 
102.8 4.6 5.3 18 D&C Well differentiated  
H adenocarcinoma 
 Adenocarcinoma -< 
 one third invasion 
 tubes and ovaries 
 normal 
42. Gowri  
1553 
PMB 58, P4L4 6 yrs 4.6x3.1x2 10.6 2.8 1.3 4 pencil-
line Echo 
D&C TIFD 
H Atrophic Endometrium 
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n a
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43. Subbulakshmi 
3965 
PMB 62, P4L4 8 yrs 6.7x3.8x3.6 74.08 3.6 1.8 10 D&C Secretory 
H Endometrium 
44. Thilagavathy  
4946 
PMB 48, P3L3 2 yrs 5.3x3.9x1.8 L ovary 
cystic echotexture 
(N) 
28.86 10.34 4.56 
 
17 D&C Cystoglandular 
 hyperplasia 
H Follicular cyst L. ovary 
45. Dhanam 
3979 
PMB 60, P4L4 5 yrs 4x2.6x1.4 12.53 2.3 1.4 3 DSC Atrophic 
H Entometrium 
46. Chandra  
5640 
PMB 58 P2L2 5 yrs 6x4.2x2.1myomat. 
polyp 2x1 cm 
54.18 2.4 1.6 7 D&C Secretory 
H Endometrium 
47. Sampooranam 
6785 
PMB 55, P1L1 3 yrs 7.2x4.3x2.4 67.13 2.6 2.8 12 D&C Secretory 
H Endometrium 
48. Kanchana 
6781  
PMB 56, P3L3 2 yrs 3.8x2.4x1.2 14.16 2.3 1.2 4 pencil-
line echo 
D&C Atrophic 
H Endometrium 
49. Saroja 
7519 
PMB 59 P2L2 6 yrs 6x3.8x2.2 43.16 2.4 1.8 8 D&C Secretory 
H Endometrium 
50. Kuppammal  
6778 
PMB 66 P4L4 16 yrs 6.3x4.2x3 45.58 3.4 2.3 10 D&C Endometritis pus 
 poured out 
H Secretory endometrium 
 
PMB - Post Menopausal bleeding 
NSE  - Non Secretory Endometrium 
TIFD - Tissue insufficient for diagnosis 
D&C - Dilatation and curettage 
H - Hysterectomy  
  
GROUP B : WOMEN WITH PERIMENOPAUSAL BLEEDING 
 
Trans-vaginal Sonogram Findings 
Ovarian 
Volume 
Sl. 
No. Name I.P. No. 
P
r
o
v
i
s
i
o
n
a
l
 
D
i
a
g
n
o
s
i
s
 
Age, 
Parity 
Menopause 
associated 
risk factors 
Uterine size & 
associated findings 
(cms) 
Endom
etrial 
Volume 
(cm3) 
Lt Rt. 
Endometr
ial 
Thickness 
(mm) 
Histopathology Report 
1. Kalaiselvai  
5372 
DUB 41, P2L2 - 1.2x2.3x2.6 18.16 3.6 5.8 6 D&C N.S.E 
H 
2. Dhanam  
5387 
DUB 40, P3L3 - 6.3x4.8x2.2 58.14 4.3 3.6 8 D&C N.S.E 
H 
3. Aruna 
7623 
DUB 44 P2L2 - 6.6x7.2x2.3Small 
intramural fibroid 
posterior wall 
67.12 5.1 2.8 9 D&C N.S.E. 
H 
4. Rajeswari 
7627 
DUB 
with 
white 
disch
arge 
43 P4L4 - 4x5.2x4.1 135.43 3.4 4.7 15 D&C  Cystoglandular 
H Hyperplasia 
5. Punitha 
7628 
DUB 42, P2L2 - 6.40x5.7x2.8 28.16 2.8 2.4 12 D&C N.S.E. 
H 
6. Mahalakshmi 
8022 
DUB 45 P1L1 - 7.1x4.2x1.8 37.68 3.6 4.2 10 D&C Proliferative phase 
H 
7. Chitra 
8451 
DUB 46, P2L2 - 8x3.8x2.4 
Adenomyosis 
43.18 2.6 2.3 9 D&C Secretory 
H 
8. Thulasi  
8024 
DUB 40 P3L3 Hypertensi
on 
6x4.8x3.6 125.05 2.5 3.2 14 D&C cystoglandular 
H Hyperplasia 
9. Jothi 
720 
DUB 47, Nalli 
para 
- 6.4x3.8x2.6 48.16 4.2 5.36 18 D&C Endometritis 
H 
Sl. Name I.P. No. 
n a
l
 
D
Age, Menopause Trans-vaginal Sonogram Findings Histopathology Report 
Ovarian 
Volume 
No.   Parity associated 
risk factors Uterine size & 
associated findings 
(cms) 
Endom
etrial 
Volume 
(cm3) 
Lt Rt. 
Endometr
ial 
Thickness 
(mm) 
 
10. Kalayani 
718 
DUB 43 P3L3 - 7.6x3.4x2.2x 
Adenomyosis R 
ovary cystic 
36.43 3.84 10.26 10 D&C Secretory Endometrium 
H Adenomyosis 
11. Umayal 
1686 
DUB 45 P2L2 - 8x4.6x3.2 120.14 4.2 3.8 16 D&C Cystoglandular 
H Hyperplasia 
12. Sudha 
1672 
DUB 40 P4L4 - 7.2x4.8x2.6 56.18 3.6 4.8 11 D&C N.S.E 
H 
13. Ponmani  
2009 
DUB 42 P3L2 - 5.3x4.6x2.1 
R ovary cystic 
52.19 3.6 13.86 8 D&C N.S.E 
H Submucous myomatous 
 polyp 2x3.2cm R ovary 
 follicular cyst L ovary 
 normal 
14. Rohini  
6363 
DUB 44 P3L3 - 7.6x6.2x2.3 
Adenomyosis R 
ovary cystic 
110.48 3.2 8.3 7 D&C N.S.E 
H 
 
15. Banumathy 
1302 
DUB 40 P2L2 Diabetes 6x4.3x2.2 54.92 4.2 2.8 6 D&C N.S.E 
H 
16. Poongavanam 
1633 
DUB 43 P2L2 - 6.8x5.2x2.2 67.19 2.9 3.4 13 D&C Cystoglandular 
H Hyperplasia  
17. Padma 
1619 
DUB 49, Nalli 
parous 
Hypertensi
on 
6x4.3x3.2 68.18 4.7 3.2 12 D&C N.S.E 
H 
18. Durga 
2275 
DUB 40 P2L2 - 7.2x6.2x2.6 
Adenomyosis both 
ovaries cystic 
normal echotexture 
102.64 7.6 12.58 18 D&C Cystoglandular 
 hyperplasia 
H Adenomyosis both 
 ovaries follicularcyst 
Sl. Name I.P. No. 
n a
l
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Ovarian 
Volume 
No.   Parity associated 
risk factors Uterine size & 
associated findings 
(cms) 
Endom
etrial 
Volume 
(cm3) 
Lt Rt. 
Endometr
ial 
Thickness 
(mm) 
 
19. Ponmathi  
1314 
DUB 42 P3L3 - 4.8x3.6x2 36.74 3.6 5.8 9 D&C N.S.E 
20. Mari 
2595 
DUB 
with 
white 
disch
arge 
40 P3L3 - 7x4.6x2.8 38.16 2.8 4.3 8 D&C N.S.E. 
H 
21. Vijaya 
1904 
DUB 41 P2L1 - 8x4.3x3.8 45.86 2.3 2.2 7 D&C N.S.E 
H 
22. Bakir 
2818 
DUB 45 P1L1 - 8.4x5.6x3.2 67.18 5.2 4.6 13 D&C cystoglandular 
H Hyperplasia 
23. Chitra 
4901 
DUB 48 P2L2 - 8.2x4.8x3.6 116.86 2.8 2.4 8 D&C N.S.E 
H 
24. Sagayam 
6949 
DUB 42 P2L2 - 6.2x4.2x2.8 152.18 3.6 4.2 12 D&C Secretory 
H Endometrium 
25. Mohana  
8234 
DUB 48 P3L3 Hypertensi
on DM 
Uterus 8.6x5.2x4 
Asymmetrical thick 
endometrial echo 
25mm loss of 
subendometrial 
halo. Myometrium 
less than one third 
invasion  
160.36 3.6 4.4 25 D&C Adenocarcinoma 
H Adenocarcinoma 
 Endometrium 
 Myometrium  less than 
 one third invasion 
26. Gowri 
8620 
 
DUB 43 P4L4 - 10x5.2x3.6 
Adenomyosis 
152 4.78 3.8 10 D&C N.S.E 
H 
Sl. Name I.P. No. 
n a
l
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Ovarian 
Volume 
No.   Parity associated 
risk factors Uterine size & 
associated findings 
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Endom
etrial 
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Lt Rt. 
Endometr
ial 
Thickness 
(mm) 
 
27. Unnamalai 
8624 
DUB 46 P4L4 - 7x4.6x3.4 94.26 4.3 3.1 7 D&C  N.S.E 
H 
28. Vela  
2070 
DUB 46 P4L4 - 8.6x3.9x4.7 
Submucous 
myomatous polyp 
3x4.2cm within 
cavity 
146.43 5.8 3.6 10 D&C N.S.E 
H Submucous polyp 
 3x4.2cm 
29. Sadeeshwari 
6415 
DUB 42 P3L3 - 7.2x4.3x2.8 67.98 4.2 5.6 17 D&C Cystoglandular 
H Hyperplasia 
30. Komala  
6844 
DUB 40 P4L4 Hypertensi
on 
6.7x3.8x2.6 
Myomatous polyp 
within cavity 
1.8x2cm 
45.16 3.6 4.1 8 D&C N.S.E 
H Submucous 
 myomatous polyp 
 1.6x2.2cm 
 
31. Malliga 
7935 
DUB 46 P2L2 - 5.1x4.2x2.6 58.16 3.9 5.7 10 D&C N.S.E 
H 
32. Shenbagavalli 
8381 
DUB 
 
41 P2L2 - 4.6x4.3x2.8 50.18 3.72 5.94 7 D&C proliferative 
H Endometrium 
33. Maheswari  
9828 
DUB 48 P3L3 - 8.8x7.8x3.2 
myomatous polyp 
3x2.8cm with cavity 
210.68 3.4 4.5 24 D&C  Atypical hyperplasia 
H Myomatous polyp 
 2.6x3.2cm 
34. Devi  
6308 
DUB
with 
white 
disch
arge 
42, P4 L4 - 8.6x4.8x5 
Adenomyosis 
216.98 4.2 3.6 18 D&C cystoglandular 
 hyperplasia 
H Adenomyosis 
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n a
l
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35. Rajammal  
1632 
DUB 44, P3L3 - 5.4x4.3x3.2  
Endometrium polyp 
1 x 1cm 
32.16 3.2 2.8 8 D&C N.S.E 
H 
36. Kala 
8338 
DUB 41, P2L2 - 6.2x4.6x2.3 38.3 2.4 2.8 10 D&C Secretory 
 Endometrium 
H Endometrium polyp 
 1x2cm 
37. Ponnammal 
8625 
DUB 43, P2L1 - 5x4.2x3.8 47.46 4.6 3.2 9 D&C N.S.E 
H 
38. Sorna 
2788 
DUB 49, P4L3 Hypertensi
on 
7x4.6x3.4 
myomatous polyp 
near fundus R ovary 
cystic 
95.16 2.6 6.4 10 D&C proliferative  
 endometrium  
H Leiomyomatous polyp 
 near fundus 3x2.6cm 
39. Valliammal 
1908 
DUB 45, P1L1 - 7x5.6x3.2 57.18 4.6 5.3 11 D&C N.S.E. 
H 
40. Pappathi  
2279 
DUB 42, P3L3 - 6.7x3.6x2.5 58.14 3.8 4.12 16 D&C cystoglandular 
H hyperplasia 
41. Kannagi  
1304 
DUB 44, P2L2 - 7.2x5.2x4.2 52.3 5.7 3.8 11 D&C N.S.E 
H  
42. Kamatchi 
1620 
DUB 50, P3L3 DM 9x5.6x3.2 
Asymmetrical thick 
endometrial echo 
28mm loss of 
subendometrial 
halo. Myometrium 
less than one third 
invasion 
134.56 3.2 4.3 28mm D&C Adenocarcinoma 
H Adenocarcinoma 
 Endometrium 
 Myometrium  less than 
 one third invasion  
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n a
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43. Kavitha 
678 
DUB 
with 
white 
disch
arge 
48, P2L2 - 8x5.8x4.3 65.7 4.3 2.6 8 D&C Proliferative 
H Hyperplasia 
44. Selvi 
6048 
DUB 42, P4L4 - 6.4x5.2x4.4 146.78 3.6 4.8 22 D&C Adenomatous  
H Hyperplasia 
45. Lakshmi 
3064 
DUB 43, P2L2 - 6.2x5.2x4.3 72.63 2.2 2.6 9 D&C N.S.E 
H 
46. Malar 
860 
DUB 42, P4L4 Hypertensi
on 
7.2x4.6x2.3  
Fibroid posterior 
wall R Ovary cystic 
65.76 4.76 6.8 15 D&C Cystoglangular 
H Hyperplasia Fibroid 
 posterior wall R Ovary 
 cystic 
47. Sheela 
786 
DUB 40, P3L3 - 7x4.3x2.2 30.13 2.3 3.6 7 D&C N.S.E 
H 
48. Poongodi 
6845 
DUB 46, P2L2 - 8x6.1x2.6 
Adenomyosis R 
ovary cystic 
125.08 4.4 6.2 10 D&C Adenomyosis 
H N.S.E 
49. Indirani 
9464 
DUB 47, P3L3 HT, DM 6x4.3x2.2 32.16 4.8 2.3 6 D&C N.S.E. 
H 
50. Maheswari 
9822 
DUB 40, P2L2 - 5.8x4.6x2.8 56.68 3.8 4.3 14 D&C cystoglandular 
H Hyperplasia 
NSE  - Non Secretory Endometrium 
D&C - Dilatation and curettage 
H - Hysterectomy  
 
ABOUT 10 CASES STUDIED WITH DIAGNOSTIC HYSTEROSCOPY AND HYSTEROSCOPIC GUIDED D&C 
 
 
I. PERIMENOPAUSAL BLEEDING - 5 CASES 
 
 
Sl. No. Name I.P.No. Provisional 
Diagnosis 
Age, 
Parity 
Hysteroscopy Findings HPE Report 
1. Parveen Banu 
787 
DUB 
 
47, P2L2 Endometrial polyp 2x3cm D&C N.S.E 
H Endometrial polyp 2 x 3cm 
2. Saroja 793 DUB 42, P3L3 Submucousal mysomatous polyp 
1x2 cm 
D&C Adenomatous hyperplasia 
H Lost for follow up 
3. Rani 1067 
 
DUB 40 P2L2 Normal Endometrium D&C N.S.E 
H 
4. Kanchana 683 DUB 45 P3L3 Proliferative Endometrium D&C Proliferative Endometrium 
H Adenomyosis 
5. Ellammal 
1350 
DUB 41 P4L4 Endocervical Polyp 1x1cm D&C Adenomatous hyperplasia 
H Endocervical polyp 1x1.5cm 
 
 I. POSTMENOPAUSAL BLEEDING - 5 CASES 
 
 
Sl. No. Name I.P.No. Provisional Diagnosis 
Age,   
Parity Hysteroscopy Findings HPE Report 
1. Rukhmani 
1651 
PMB 58, P4L4 Atrophic Endometrium D&C Atrophic 
H Endometrium   
2. Sengammal 
1218 
PMB 57, P5L3 Endometritis D&C Endometritis 
H Lost for followup 
3. Parimala 
1313 
PMB 53, P2L2 Submucous myomatous polyp 
2x2cm 
D&C Secretory Endometrium 
H Submucous polyp 2x3cm 
4. Kuppammal 
1057 
PMB 65 P5L5 Atrophic Endometrium D&C TIFD  
H Atrophic Endometrium 
5. Kamalam 
988 
PMB 60, P2L2 Atrophic Endometrium D&C Atrophic  
H Endometrium 
 
 
 
PROFORMA 
Measurement of endometrial thickness in women with peri 
and post menopausal bleeding and its correlation with 
histopathology. 
Name  :  Age:   I.P.No. : 
D.O.A :  Residence 
D.G.D. :  
C/o.  : Bleeding pv or  
discharge pv. 
 
HISTORY OF PRESENT ILLNESS 
 
Bleeding pv since  
Profuse/Moderate/scanty  
H/o of passing clots  
Discharge pv since. 
 
Menstrual RIo 
 
Age of Menarche  
Menstrual cycle  regular/irregular    /days 
Profuse/Moderate/Scanty 
Dysmenorrhoea  Present /Absent 
Inter Menstrual bleeding 
Date of L.M.P. 
Menopause   Attained/Not attained 
 Years 
 
Treatment H/o 
Earlier Contraceptive History  
Oral Contraceptive Piles 
Intra uterine contraceptive device  
Hormone Replacement Therapy 
 Obstetrical H/o 
 
Married Life   Parity   Living children 
Last child birth     Sterilisation 
 
Past History   
  H/o. Tuberclosys 
  H/o. Diabetes Mellitus 
  H/o. Hypertension 
  H/o. Bleeding Disorders 
  H/o. Any D & C in the past 
  H/o. Any Surgery 
 
Family History 
 
Tuberculosis   Hypertension 
Diabetes Mellitus  Carcinoma 
 
Personal History 
 
Obesity Diet  Sleep  Micturition 
  Appetite Bowel 
 
Physical Examination 
 
General condition     Build 
Nourishment Pulse Rate    Temperature 
Pallor      B.P. 
Gums      Teeth 
Jaundice      Thyroid 
Oedema     Neck Veins 
Lymph Nodes 
 
Per Abdomen 
Vaginal Examination 
 
 Inspection of vulva 
 Palpation of external genitalia 
 
P/s.  Vagina 
  Cervix 
 
P/v.  Cervix Position   Discharge 
  Uterus Position Size  Mobile/Restricted 
  Fornices 
Investigations 
 
Blood group and Rh  
Hemogram 
Blood urea 
Serum creatinine  
Blood sugar (Random)  
Urine Analysis  
Bleeding Time  
Clotting Time 
Pap Smear 
 
Vaginal Sonography 
 
Uterus 
Endometrial Thickness  
Endometrial volume  
Cervix 
(R) Ovary 
(L) Ovary 
Ovarian volume (R)  
(L) 
Any other abnormalities 
 
Diagnosis 
 
Remarks 
 
Dilation & Curettage 
 
Endocervical curettings  
Uterine cavity sounded upto  
Regular/Irregular  
Technical difficulty  
Specimen Amount 
Biopsy Ox 
 
Hystrectomy  
 
Histopathology Report 
